Skip to main content

As the former general counsel of the U.S. Department of Health and Human Services (HHS), Bob Charrow brings to bear unparalleled experience in health care law. In January 2018, Bob was sworn in as general counsel of HHS, where he led an office of more than 600 lawyers and oversaw the chief counsel for the various agencies within the department, including the Food and Drug Administration, the Centers for Medicare & Medicaid Services, and the various Public Health Service agencies such as the National Institutes of Health and the Centers for Disease Control and Prevention. Bob serves as senior chairman of Greenberg Traurig’s Health Care & FDA Practice.

While at HHS, Bob helped to lead the U.S. government’s response to the coronavirus pandemic. Bob was at the epicenter of the legal issues triggered by the unprecedented global health crisis. He also actively participated in formulating department policy with respect to Medicare reimbursement, fraud and abuse, the Affordable Care Act, the PREP Act, drug and device approvals, drug pricing, including 340B issues, tort liability, and technology transfer.

Bob focuses his practice on research, biotechnology and health care issues. He represents health care providers, insurers, pharmaceutical companies, universities, research institutes and other entities with respect to regulatory and litigation matters arising under the Federal Food, Drug, and Cosmetic Act, Public Health Service Act, including the PREP Act, Medicare, Medicaid and Affordable Care Act, and fraud and abuse issues that may arise under the False Claims Act and other federal laws.

Bob represents corporations, political action committees, and candidate committees with respect to issues arising under the Federal Election Campaign Act of 1971, as amended, and ancillary legislation. He also participates regularly in preparing Supreme Court briefs and certiorari petitions.

Bob previously served as a board member of Operation Warp Speed, a member of the senior staff at the AIDS Coordinating Council, the Attorney General’s Task Force on Tort Reform, and the Secretary’s Task Force on Medical Liability, and was chairman of the Task Force on Scientific Misconduct. He served as deputy chief counsel to Reagan-Bush ‘84, the president’s authorized campaign committee, and also taught as an associate professor of law at University of Cincinnati College of Law.

Bob has written extensively in the area of science and the law, and in particular on the effects of the legal system on scientific research, product development and health.

Concentrations

  • Health law
  • Appellate litigation
  • Administrative law
  • Food, drug, and cosmetic law
  • Tort law
  • Litigation
  • Campaign finance law

Expertise

Erfahrung

  • Fisher v. University of Texas, 133 S.Ct. 2411 (2013).
  • Gratz v. Bollinger, 539 U.S. 244 (2003).
  • Grutter v. Bollinger, 539 U.S. 306 (2003).
  • Murphy Bros., Inc. v. Michetti Pipe Stringing, 526 U.S. 344 (1999).
  • Kumho Tire Co. v. Carmichael, 526 U.S. 137 (1999).
  • United States v. Winstar Corp., 518 U.S. 839 (1996).
  • Medtronic, Inc. v. Lohr, 518 U.S. 470 (1996).
  • Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993).
  • Cacchillo v. Insmed, Inc., No. 13-0963 (2d Cir. Jan. 7, 2014).
  • Bayou Lawn & Landscape v. Solis, 713 F. 3d 1080 (11th Cir. 2013).
  • Sherley v. Sebelius, 644 F.3d 388 (D.C. Cir. 2011).
  • Cacchillo v. Insmed, Inc., 638 F.3d 401 (2nd Cir. 2011).
  • Mann v. Heckler & Koch Def., 630 F.3d 338 (4th Cir. 2010).
  • Schering-Plough Healthcare Prods., Inc. v. Schwarz Pharma, Inc., 586 F.3d 500 (7th Cir. 2009).
  • Chamber of Commerce of the United States of Am. v. Chertoff, 552 F.Supp.2d 999 (N.D. Cal. 2007), appeal dismissed, No. 07-17241 (9th Cir. Nov. 7, 2009).
  • Shotz v. American Airlines, Inc., 420 F.3d 1332 (11th Cir. 2005).
  • In Re Estate of Sigourney, 93 Cal.App.4th 593 (2001).
  • NAPHS v. Shalala, 120 F. Supp.2d 33 (D.D.C. 2000).
  • General Counsel, U.S. Department of Health and Human Services, 2018-2021
  • Principal Deputy General Counsel and Deputy General Counsel, U.S. Department of Health and Human Services, 1985-1989

Anerkennung durch den Markt

  • Listed, Super Lawyers magazine, Washington, D.C. Super Lawyers, 2014-2017
  • Selected,  "Life Science Star," LMG Life Sciences, 2016-2017
  • Team Member, a Law360 "Appellate Practice Group of the Year," 2010
  • Rated, AV Preeminent® 5.0 out of 5.0

AV®, AV Preeminent®, Martindale-Hubbell DistinguishedSM and Martindale-Hubbell NotableSM are certification marks used under license in accordance with the Martindale-Hubbell® certification procedures, standards and policies.

  • Co-Principal Investigator, National Science Foundation
  • Member, Advisory Board, BNA Medical Research Law & Policy Report
  • Member, American Law Institute
  • Member, Board of Advisors, Institute of Human Virology, University of Maryland
  • Member, Secretary’s Advisory Committee on Organ Transplantation
  • Vice Chair, American Bar Association, Health Law Section, Clinical Research Interest Group

Ausbildung

Akademische Ausbildung
  • J.D., Stanford Law School, 1969
  • B.S., Harvey Mudd College, 1966
Zulassung
  • District of Columbia
  • Supreme Court of the United States
  • U.S. Court of Appeals for the District of Columbia Circuit
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Court of Appeals for the Fifth Circuit
  • U.S. Court of Appeals for the Fourth Circuit
  • U.S. Court of Appeals for the Ninth Circuit
  • U.S. Court of Appeals for the Second Circuit
  • U.S. Court of Appeals for the Seventh Circuit
  • U.S. Court of Appeals for the Third Circuit